Philip Maccarthy

Showing 1-7 of 7 articles

Author Francesco Maria Lauri

Coronary interventions

Angiography-derived functional assessment of non-culprit coronary stenoses during primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Lauri F, Macaya F, Mejia-Renteria H, Goto S, Yeoh J, Nakayama M, Quiros A, Liontou C, Pareek N, Fernández-Ortíz A, Macaya C, Maccarthy P, Escaned J

September 24, 2019 | 10.4244/EIJ-D-18-01165

Author Miriam Silaschi

Interventions for valvular disease

Dynamic transcatheter mitral valve repair: a new concept to treat functional mitral regurgitation using an adjustable spacer

Silaschi M, Nicou N, Eskandari M, Aldalati O, Seguin C, Piemonte T, McDonagh T, Dworakowski R, Byrne J, Maccarthy P, Monaghan M, Wendler O

June 20, 2017 | 10.4244/EIJ-D-16-00970

Author Dinesh Natarajan

Interventions for valvular disease

Will PARTNER change my practice? Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A trial – transcatheter or surgical aortic-valve replacement in intermediate-risk patients

Natarajan D, Makkar R, Maccarthy P, Eltchaninoff H, Søndergaard L, Prendergast B

August 20, 2016 | 10.4244/EIJV12I6A131

Author Omar Aldalati

Further refining the technique: new concepts in TAVI research

Aldalati O, Maccarthy P

September 22, 2015 | 10.4244/EIJV11I5A100

Author Refai Showkathali

“Incidental findings” during TAVI work-up: more than just an inconvenience

Showkathali R, Sen A, Brickham B, Dworakowski R, Wendler O, Maccarthy P

August 20, 2015 | 10.4244/EIJY14M06_04

Author Marko Noc

Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for Life (SFL) groups

Noc M, Fajadet J, Flensted Lassen J, Kala P, Maccarthy P, Olivecrona G, Windecker S, Spaulding C

May 20, 2014 | 10.4244/EIJV10I1A7

Author David Hildick-Smith

Complications of transcatheter aortic valve implantation: avoidance and management

Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, Maccarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N

September 30, 2011 | 10.4244/EIJV7I5A99

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke